Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Ryoji Tatsumi"'
Autor:
Tomoaki Nakajima, Yoshiyasu Karino, Shuhei Hige, Hirokazu Suii, Ryoji Tatsumi, Masakatsu Yamaguchi, Tomohiro Arakawa, Yasuaki Kuwata, Joji Toyota
Publikováno v:
Annals of Hepatology, Vol 27, Iss 1, Pp 100566- (2022)
Introduction and objectives: Sustained virologic response (SVR) is achieved in most cases of C-type liver disease after direct-acting antiviral (DAA) therapy. Although liver fibrosis improves, the degree of improvement is different. This study aimed
Externí odkaz:
https://doaj.org/article/d659d04c2d2e4abe8c4707760d54fff6
Autor:
Hideto Kawaratani, Yasuteru Kondo, Ryoji Tatsumi, Naoto Kawabe, Norikazu Tanabe, Akira Sakamaki, Kazuo Okumoto, Yoshihito Uchida, Kei Endo, Takumi Kawaguchi, Tsunekazu Oikawa, Yoji Ishizu, Shuhei Hige, Taro Takami, Shuji Terai, Yoshiyuki Ueno, Satoshi Mochida, Yasuhiro Takikawa, Takuji Torimura, Tomokazu Matsuura, Masatoshi Ishigami, Kazuhiko Koike, Hitoshi Yoshiji
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 6, p 1571 (2022)
Background: Rifaximin is commonly used for hepatic encephalopathy (HE). However, the effects of long-term treatment for Japanese people are limited. Therefore, this study aimed to investigate the effects and safety of long-term treatment with rifaxim
Externí odkaz:
https://doaj.org/article/b231735f1f094e809ce497a213c10038
Autor:
Hirokazu Suii, Itaru Ozeki, Ryoji Tatsumi, Masakatsu Yamaguchi, Mutsuumi Kimura, Tomohiro Arakawa, Tomoaki Nakajima, Yasuaki Kuwata, Takumi Ohmura, Shuhei Hige, Yoshiyasu Karino, Joji Toyota
Publikováno v:
Case Reports in Hepatology, Vol 2017 (2017)
Interferon (IFN) and ribavirin (RBV) combination therapy was previously the standard of care for treatment of hepatitis C virus (HCV) genotype 2 infection. But, it often induced hemolytic anemia. In 2014, sofosbuvir (SOF) was approved for the treatme
Externí odkaz:
https://doaj.org/article/23cfa00cf20f4f2f9b8d02ccaeb67c97
Autor:
Joji Toyota, Ryoji Tatsumi, Masakatsu Yamaguchi, Hirokazu Suii, Tomohiro Arakawa, Shuhei Hige, Yasuaki Kuwata, Tomoaki Nakajima
Publikováno v:
Internal Medicine
Objective This study evaluated the efficacy associated with switching to rifaximin in patients with hepatic cirrhosis receiving kanamycin sulfate for the treatment of hepatic encephalopathy and hyperammonemia. Methods We included 37 patients who swit
Autor:
Tomohiro Arakawa, Hirokazu Suii, Joji Toyota, Shuhei Hige, Yasuaki Kuwata, Yoshiyasu Karino, Masakatsu Yamaguchi, Tomoaki Nakajima, Ryoji Tatsumi
Publikováno v:
Annals of Hepatology, Vol 27, Iss 1, Pp 100566-(2022)
Introduction and objectives: Sustained virologic response (SVR) is achieved in most cases of C-type liver disease after direct-acting antiviral (DAA) therapy. Although liver fibrosis improves, the degree of improvement is different. This study aimed
Autor:
Tomoaki Nakajima, Tomohiro Arakawa, Ryoji Tatsumi, Yoshiyasu Karino, Itaru Ozeki, Yasuaki Kuwata, Masakatsu Yamaguchi, Hirokazu Suii, Joji Toyota
Publikováno v:
Hepatology Research. 50:488-501
Aim In Japan, no zinc preparation had been approved for therapeutic purposes before March 2017. Zinc acetate hydrate was recently approved for the treatment of hypozincemia. We evaluated the efficacy and safety of treatment with zinc acetate hydrate.
Autor:
Hirokazu Suii, Joji Toyota, Tomoaki Nakajima, Masakatsu Yamaguchi, Tomohiro Arakawa, Ryoji Tatsumi, Yasuaki Kuwata, Itaru Ozeki
Publikováno v:
Hepatology Research
Aim This study aimed to determine the distributions of serum zinc levels and the prevalence of zinc deficiency in patients with chronic liver disease (CLD) in actual clinical practice, and to analyze the association between serum zinc levels and clin
Autor:
Tomoaki Nakajima, Shuhei Hige, Tomohiro Arakawa, Takashi Hasegawa, Ysuaki Kuwata, Joji Toyota, Masakatsu Yamaguchi, Hirokazu Suii, Yoshiyasu Karino, Ryoji Tatsumi
Publikováno v:
Journal of gastroenterology and hepatologyReferences. 36(2)
BACKGROUND AND AIM Since the advent of direct-acting antiviral (DAA) therapy, the total eradication of hepatitis C virus has been achievable with the recovery of hepatic reserve after achievement of sustained virologic response (SVR). Hence, here, we
Autor:
Ryoji Tatsumi, Tomohiro Arakawa, Hirokazu Suii, Tomoaki Nakajima, Yasuaki Kuwata, Itaru Ozeki, Masakatsu Yamaguchi
Publikováno v:
J Clin Biochem Nutr
The recently approved direct-acting antivirals (DAA) agents are effective in terms of sustained virologic response (SVR) rates and are well tolerated in most hepatitis C virus (HCV) patients. This study aimed to analyze the association between serum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb35954821c3f5d10c7a875e8760dd67
https://europepmc.org/articles/PMC7263932/
https://europepmc.org/articles/PMC7263932/
Autor:
Tomoaki Nakajima, Itaru Ozeki, Ryoji Tatsumi, Tomohiro Arakawa, Yasuaki Kuwata, Masakatsu Yamaguchi, Hirokazu Suii
Publikováno v:
J Clin Biochem Nutr
This study aimed to analyze the association between serum zinc levels and major subjective symptoms in zinc deficiency patients with chronic liver disease. 578 patients with chronic liver disease were enrolled. The patients, whose serum zinc level of